Judith Lin, MD
Vascular Surgery · Detroit, MINPI 1306909932
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $12,655 of the $15,350 with a category attached, or 82.4%. Medtronic accounts for 69.7% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $9,781 and has fallen 99.2% since, to $82 in 2025.
Across 81 payments — averaging $189.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$11K
- Medical Device Business Services, Inc.$2K
- W. L. Gore & Associates, Inc.$1K
- Penumbra, Inc.$280
- Medistim USA, Inc.$238
- Shockwave Medical, Inc$121
- plus $554 from 15 others
Across 4 payments — averaging $20,713 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$83K
What the payments were for
- Travel & lodging$12,65582%
- Food & beverage$2,39516%
- Education$2992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 43 | $10,705 |
| Medical Device Business Services, Inc. | 6 | $2,153 |
| W. L. Gore & Associates, Inc. | 8 | $1,298 |
| Penumbra, Inc. | 3 | $280 |
| Medistim USA, Inc. | 1 | $238 |
| Shockwave Medical, Inc | 1 | $121 |
| Angiodynamics, Inc. | 2 | $113 |
| BD | 2 | $90 |
| Integra Lifesciences Corporation | 2 | $73 |
| Davol Inc. | 1 | $32 |
| AbbVie | 1 | $30 |
| Philips North America LLC | 2 | $29 |
| Convatec Inc. | 1 | $26 |
| Acera Surgical, Inc. | 1 | $25 |
| ABC Home Medical Supply, Inc. | 1 | $22 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Edwards Lifesciences | 1 | $19 |
| Abbott | 1 | $19 |
| Stryker | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,350 in reported general payments places this provider in the 80th percentile of 183 vascular surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $14,775 |
| XareltoRivaroxaban | 20 | $10,872 |
| Cilostazol | 32 | $786 |
| ClopidogrelClopidogrel Bisulfate | 21 | $396 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $18 | $10,87220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 183 vascular surgery providers in Michigan.
Other vascular surgery in Detroit
- Kevin OnofreyDetroit$65K
- Yevgeniy RitsDetroit$57K
- Kyle MarkelDetroit$33K
- Andi PeshkepijaDetroit$24K
- Loay KabbaniDetroit$19K
- Alice LeeDetroit$14K
- Sun KimDetroit$11K
- David LorelliDetroit$7K
- Michael PerryDetroit$7K
- Nicolas MouawadWest Branch$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.